EZH2 and cervical carcinoma: In this study, EZH2 inhibitors EPZ6438 and ZLD1039 have been investigated for their cytotoxicity, apoptosis induction, and cell cycle arrest following their exposure on HPV+ and HPV- cervical cancer cells.